Publication: Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.
dc.contributor.author | Barbarroja, Nuria | |
dc.contributor.author | Arias-de la Rosa, Ivan | |
dc.contributor.author | Lopez-Medina, Clementina | |
dc.contributor.author | Camacho-Sanchez, Maria Del Rosario | |
dc.contributor.author | Gomez-Garcia, Ignacio | |
dc.contributor.author | Velez Garcia-Nieto, Antonio | |
dc.contributor.author | Escudero-Contreras, Alejandro | |
dc.contributor.author | Lopez-Pedrera, Chary | |
dc.contributor.author | Lopez-Montilla, Maria Dolores | |
dc.contributor.author | Collantes-Estevez, Eduardo | |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.contributor.funder | Fondo europeo de desarrollo regional de la Union Europea, | |
dc.contributor.funder | Junta de Andalucia | |
dc.date.accessioned | 2023-02-08T14:49:23Z | |
dc.date.available | 2023-02-08T14:49:23Z | |
dc.date.issued | 2019-10-16 | |
dc.description.abstract | Cardiovascular disease (CVD) is the main cause of mortality in patients with psoriatic disease. Traditional cardiovascular (CV) risk factors, such as arterial hypertension (HTA), type 2 diabetes (T2D), and dyslipidaemia are more prevalent in these patients compared with the general population.1 Besides, the chronic inflammatory state induced by psoriatic disease contributes to subclinical atherosclerosis, making it possible to consider psoriatic disease as an independent CV risk factor.2 In fact, accelerated atherosclerosis has been associated with both psoriasis and psoriatic arthritis (PsA), progression of which is responsible for the majority of CVD mortality in these patients | |
dc.identifier.citation | Barbarroja N, Arias-de la Rosa I, López-Medina C, Camacho-Sánchez MDR, Gómez-García I, Vélez-García AJ, et al. Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X19880742 | |
dc.identifier.doi | 10.1177/1759720X19880742 | |
dc.identifier.issn | 1759-720X | |
dc.identifier.pmc | PMC6796210 | |
dc.identifier.pmid | 31662800 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796210/pdf | |
dc.identifier.unpaywallURL | https://journals.sagepub.com/doi/pdf/10.1177/1759720X19880742 | |
dc.identifier.uri | http://hdl.handle.net/10668/15522 | |
dc.journal.title | Therapeutic advances in musculoskeletal disease | |
dc.journal.titleabbreviation | Ther Adv Musculoskelet Dis | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Reina Sofía | |
dc.organization | Instituto Maimónides de Investigación Biomédica de Córdoba-IMIBIC | |
dc.page.number | 3 | |
dc.publisher | Sage Publications | |
dc.pubmedtype | Journal Article | |
dc.relation.projectID | PI17/01316 | |
dc.relation.publisherversion | https://journals.sagepub.com/doi/abs/10.1177/1759720X19880742?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject | Arthritis, psoriatic | |
dc.subject | Cardiovascular diseases | |
dc.subject | Diabetes mellitus, type 2 | |
dc.subject | Technology assessment, biomedical | |
dc.subject.decs | Aterosclerosis | |
dc.subject.decs | Dislipidemias | |
dc.subject.decs | Factores de fiesgo | |
dc.subject.decs | Hipertensión | |
dc.subject.decs | Inflamación | |
dc.subject.mesh | Psoriasis | |
dc.subject.mesh | Risk factors | |
dc.subject.mesh | Hypertension | |
dc.subject.mesh | Inflammation | |
dc.subject.mesh | Atherosclerosis | |
dc.subject.mesh | Dyslipidemias | |
dc.title | Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 11 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1